ImmuCell Corporation

NASDAQ: ICCC · Real-Time Price · USD
6.09
-0.63 (-9.38%)
At close: Aug 15, 2025, 3:59 PM
6.19
1.64%
After-hours: Aug 15, 2025, 04:10 PM EDT

ImmuCell Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
8.07B 7.75M 6.01M 5.47M 7.26M 5.1M 5.4M 3.53M 3.45M 3.91M 4.8M 3.86M 6M 5.44M 5.15M 4.54M 4.11M
Cost of Revenue
4.71B 4.92M 4.43M 4.24M 4.96M 3.84M 4.13M 2.49M 3.15M 2.92M 2.95M 2.15M 2.9M 2.88M 2.73M 2.47M 2.5M
Gross Profit
3.35B 2.83M 1.58M 1.23M 2.3M 1.26M 1.27M 1.04M 300.77K 992.4K 1.85M 1.71M 3.1M 2.56M 2.42M 2.07M 1.6M
Operating Income
1.12B 622K -574.89M -1.39M -300.05K -1M -1.18M -1.3M -2.26M -1.63M -617K -592.76K 792.99K 145.03K 271.09K 215.51K -374.63K
Interest Income
n/a 25.42K 7.88K 13.26K 9.53K n/a 23.7K 14.81K 40.63K 64.72K 55.01K 26.19K 7.19K 5.31K 5.52K 5.02K 2.96K
Pretax Income
1.45B 521K -700.35K -1.53M -436.53K -1.14M -939.77K -1.38M -2.31M -1.67M -651K -683K 736.81K 75.38K 155.81K 141.11K -441.3K
Net Income
1.45B 515K -701.69K -1.53M -437.87K -1.14M -940K -1.38M -2.32M -1.67M -655K -684.15K 735.67K 74.43K 147.76K 141.11K -441.3K
Selling & General & Admin
856.66M 1.39M 1.37M 1.59M 1.33M 1.2M 1.33M 1.25M 1.45M 1.58M 1.19M 1.19M 1.27M 1.33M 1.1M 858.71K 945.75K
Research & Development
756.85M 819K 786.14K 1.03M 1.26M 1.07M 1.12M 1.1M 1.11M 1.05M 1.27M 1.14M 1.04M 1.09M 1.05M 1M 1.03M
Other Expenses
622.84M n/a n/a n/a n/a n/a n/a n/a 107.00 n/a n/a 60.00 852.00 n/a -116 n/a n/a
Operating Expenses
2.24B 2.21M 2.16B 2.62M 2.6M 2.26M 2.45M 2.35M 2.56M 2.63M 2.46M 2.33M 2.31M 2.42M 2.15M 1.86M 1.98M
Interest Expense
n/a 125.39K 133.34K 142.39K 146K n/a 144.62K 88.58K 89.98K 93.65K 89.43K 90.24K 75.21K 76.78K 78.53K 79.42K 79.64K
Selling & Marketing Expenses
856.66M 836.15K 844.04K 984.96K 800.92K 671.51K 817.49K 719.79K 879.43K 992.56K 726.74K 659.24K 811.5K 889.93K 656.42K 436.98K 520.6K
Cost & Expenses
6.95B 7.13M 6.59B 6.86M 7.56M 6.1M 6.58M 4.84M 5.7M 5.54M 5.41M 4.48M 5.21M 5.3M 4.88M 4.33M 4.48M
Income Tax Expense
1.9M 6K 1.34M 1.34K 1.34K 2K 229.00 1.52K 1.52K 1.84K 4K 1.15K 1.15K 957.00 8.04K n/a n/a
Shares Outstanding (Basic)
8.98M 8.94M 8.16M 7.81M 7.75M 7.75M 7.75M 7.67M 7.72M 7.75M 7.75M 7.6M 7.74M 7.66M 7.74M 7.66M 7.22M
Shares Outstanding (Diluted)
8.98M 8.94M 8.16M 7.81M 7.75M 7.75M 7.75M 7.75M 7.75M 7.75M 7.75M 7.74M 7.79M 7.66M 7.82M 7.76M 7.22M
EPS (Basic)
0.16 0.06 -0.09 -0.2 -0.06 -0.15 -0.12 -0.18 -0.3 -0.22 -0.08 -0.09 0.09 0.01 0.02 0.02 -0.06
EPS (Diluted)
0.16 0.06 -0.09 -0.2 -0.06 -0.15 -0.12 -0.18 -0.3 -0.22 -0.08 -0.09 0.09 0.01 0.02 0.02 -0.06
EBITDA
1.12B 1.3M -574.89M -716.95K 376.73K -300.58K -94.74K -584.51K -1.56M -968.45K 70.54K 36.63K 1.44M 755.92K 855.17K 845.51K 260.48K
EBIT
n/a 645.98K -567.01K -1.39M -290.52K -985.58K -795.15K -1.29M -2.22M -1.57M -563.7K -592.76K 812.03K 152.04K 234.33K 220.53K -363.63K
Depreciation & Amortization
n/a 673.85K 675.12K 670.96K 667.25K 685K 700.41K 705.1K 665.5K 604.25K 632.32K 629.38K 625.7K 603.88K 620.84K 624.98K 622.15K